Abstract
Oral fludarabine is the first oral formulation of a purine analogue available for clinical use which has produced encouraging results in patients with B-cell chronic lymphocytic leukemia (CLL). It has a similar tolerability profile to that of the intravenous formulation. Acute tumor lysis syndrome (TLS) induced by fludarabine appears to be a fairly unusual complication during the treatment of CLL. The present report describes the case of a 78-year-old man who developed acute renal failure associated with TLS following the first course of oral fludarabine. Laboratory investigations fulfilled the TLS typical criteria, including hyperkalemia, marked hyperuricemia, hyperphosphatemia, hypocalcemia, and acute renal failure. Despite the many documented side effects of oral fludarabine, there is only one similar case of oral fludarabine-induced TLS reported to date. Conventional therapy with short-term supportive hemodialysis and a short treatment of rasburicase for 2 days achieved a complete recovery of renal function and a decrease of the urate level to within the normal range. Clinicians should be alert to this potentially life-threatening metabolic emergency among CLL patients treated with oral fludarabine.
References
Nov 5, 1992·The New England Journal of Medicine·J N FrameS Crowley
Aug 1, 1994·Australian and New Zealand Journal of Medicine·S P Mulligan, M G Dean
Apr 1, 1996·European Journal of Haematology·F NakhoulA Carter
Mar 1, 1997·Clinical and Laboratory Haematology·S KillickJ Behrens
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonJ M Sorensen
Feb 28, 2003·American Journal of Hematology·Kashif HussainLawrence H Clouse
Oct 4, 2003·Drugs·Greg L Plosker, David P Figgitt
Sep 24, 2004·British Journal of Haematology·Mitchell S Cairo, Michael Bishop
Dec 1, 2004·The Hematology Journal : the Official Journal of the European Haematology Association·Akila Ramachandran, Gautam Majumdar
Sep 24, 2005·Current Cancer Drug Targets·T RobakP Smolewski
Nov 30, 2005·European Journal of Haematology·Margit HummelRüdiger Hehlmann
Feb 10, 2006·Pharmacotherapy·Donald A HutchersonMelissa Faneuf
Jul 29, 2006·Expert Opinion on Pharmacotherapy·Thomas ElterAndreas Engert
Feb 10, 2007·Expert Review of Anticancer Therapy·Bertrand Coiffier, Catherine Riouffol
Citations
Apr 18, 2008·Onkologie·Catherine Rioufol, Bertrand Coiffier
Jan 8, 2010·Drug Design, Development and Therapy·Ann JanssensGregor Verhoef
Mar 25, 2010·British Journal of Haematology·Mitchell S CairoUNKNOWN TLS Expert Panel
Mar 23, 2012·Postgraduate Medicine·Belal M FirwanaJoseph Varon
Dec 5, 2020·Curēus·Milap DesaiRashmi Sanjay